FR2398741B1 - - Google Patents

Info

Publication number
FR2398741B1
FR2398741B1 FR7822401A FR7822401A FR2398741B1 FR 2398741 B1 FR2398741 B1 FR 2398741B1 FR 7822401 A FR7822401 A FR 7822401A FR 7822401 A FR7822401 A FR 7822401A FR 2398741 B1 FR2398741 B1 FR 2398741B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7822401A
Other versions
FR2398741A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2398741A1 publication Critical patent/FR2398741A1/fr
Application granted granted Critical
Publication of FR2398741B1 publication Critical patent/FR2398741B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
FR7822401A 1977-07-29 1978-07-28 Derives de la prostaglandine i2 et medicaments qui en contiennent Granted FR2398741A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772734791 DE2734791A1 (de) 1977-07-29 1977-07-29 Neue prostaglandin-i tief 2 -derivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2398741A1 FR2398741A1 (fr) 1979-02-23
FR2398741B1 true FR2398741B1 (fr) 1980-10-31

Family

ID=6015442

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7822401A Granted FR2398741A1 (fr) 1977-07-29 1978-07-28 Derives de la prostaglandine i2 et medicaments qui en contiennent

Country Status (26)

Country Link
US (1) US4191694A (fr)
JP (1) JPS5427556A (fr)
AT (1) AT371454B (fr)
AU (1) AU523593B2 (fr)
BE (1) BE869372A (fr)
CA (1) CA1180700A (fr)
CH (1) CH636354A5 (fr)
CS (1) CS207640B2 (fr)
DD (1) DD138904A5 (fr)
DE (1) DE2734791A1 (fr)
DK (1) DK149954C (fr)
ES (1) ES472099A1 (fr)
FR (1) FR2398741A1 (fr)
GB (1) GB2001650B (fr)
GR (1) GR72256B (fr)
HU (1) HU179346B (fr)
IE (1) IE47304B1 (fr)
IL (1) IL55236A (fr)
IT (1) IT1097554B (fr)
LU (1) LU80043A1 (fr)
NL (1) NL7806861A (fr)
NZ (1) NZ187849A (fr)
SE (1) SE443978B (fr)
SU (1) SU921465A3 (fr)
YU (1) YU41595B (fr)
ZA (1) ZA784307B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281191A (en) * 1979-04-02 1981-07-28 The Upjohn Company 19-Hydroxy-19-methyl-PG amides
US4264524A (en) * 1979-04-02 1981-04-28 The Upjohn Company 19,20-Didehydro-PG1 amides
US4283350A (en) * 1979-04-02 1981-08-11 The Upjohn Company 19,20-Didehydro-PG2 amides
US4276436A (en) * 1979-04-02 1981-06-30 The Upjohn Company 19-Keto-PG sulfonylamides
US4283351A (en) * 1979-04-02 1981-08-11 The Upjohn Company 19,20-Didehydro-13,14-dihydro-PG2 amides
US4264523A (en) * 1979-04-02 1981-04-28 The Upjohn Company 19,20-Didehydro-13,14-dihydro-PG1 amides
US4278815A (en) * 1979-04-02 1981-07-14 The Upjohn Company 19-Keto-PG amides
US4267371A (en) * 1979-07-05 1981-05-12 The Upjohn Company 19-Hydroxy-6a-carba-PGI2 amides
US4312997A (en) * 1979-07-05 1982-01-26 The Upjohn Company 19-Hydroxy-6-oxo-PGF1 amides
US4267352A (en) * 1979-07-05 1981-05-12 The Upjohn Company 19-Hydroxy-19-methyl-6-oxo-PGF1 sulfonylamides
US4289904A (en) * 1979-07-05 1981-09-15 The Upjohn Company 19-Hydroxy-6a-carba-PGI2 sulfonylamides
US4281150A (en) * 1979-07-05 1981-07-28 The Upjohn Company 19-Hydroxy-19-methyl-6a-carba-PGI2 sulfonylamides
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
DE3041602A1 (de) * 1980-10-31 1982-06-16 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 5-cyan-prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3107100A1 (de) * 1981-02-20 1982-09-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
US4539433A (en) * 1982-11-24 1985-09-03 Tdk Corporation Electromagnetic shield
JPH0284398U (fr) * 1988-12-20 1990-06-29
JPH0397493U (fr) * 1990-01-23 1991-10-07
JPH0726876Y2 (ja) * 1990-07-02 1995-06-14 日立フェライト株式会社 電波暗室用電波吸収体
KR930011548B1 (ko) * 1991-08-13 1993-12-10 한국과학기술연구원 적층형 전파흡수체
JP3340732B1 (ja) * 2001-10-05 2002-11-05 日本医薬品工業株式会社 シクロペンタベンゾフラン誘導体の製造方法及びその製造原料となる新規化合物

Also Published As

Publication number Publication date
SE443978B (sv) 1986-03-17
IT7826113A0 (it) 1978-07-26
NL7806861A (nl) 1979-01-31
DE2734791A1 (de) 1979-02-15
IE781538L (en) 1979-01-29
ES472099A1 (es) 1979-03-16
GR72256B (fr) 1983-10-06
IL55236A (en) 1982-09-30
BE869372A (fr) 1979-01-29
AU523593B2 (en) 1982-08-05
DK149954B (da) 1986-11-03
YU41595B (en) 1987-10-31
CH636354A5 (de) 1983-05-31
YU176278A (en) 1983-01-21
JPS5427556A (en) 1979-03-01
US4191694A (en) 1980-03-04
NZ187849A (en) 1981-01-23
DE2734791C2 (fr) 1990-09-06
AU3843978A (en) 1980-01-31
JPS6259700B2 (fr) 1987-12-12
SU921465A3 (ru) 1982-04-15
GB2001650B (en) 1982-03-03
ZA784307B (en) 1979-07-25
DK336878A (da) 1979-01-30
IT1097554B (it) 1985-08-31
HU179346B (en) 1982-10-28
DD138904A5 (de) 1979-11-28
ATA551578A (de) 1982-11-15
FR2398741A1 (fr) 1979-02-23
IL55236A0 (en) 1978-09-29
DK149954C (da) 1987-06-15
CS207640B2 (en) 1981-08-31
CA1180700A (fr) 1985-01-08
SE7808184L (sv) 1979-01-30
LU80043A1 (fr) 1978-12-12
GB2001650A (en) 1979-02-07
IE47304B1 (en) 1984-02-22
AT371454B (de) 1983-06-27

Similar Documents

Publication Publication Date Title
DE2822266C2 (fr)
FR2376330B1 (fr)
FR2398741B1 (fr)
FR2376858B1 (fr)
DK140303C (fr)
DE2847343C2 (fr)
DE2855342C2 (fr)
AU3353778A (fr)
FR2377415B1 (fr)
AU495917B2 (fr)
DK140972C (fr)
AR210643A1 (fr)
AU71461S (fr)
DK183377A (fr)
BG25824A1 (fr)
BG25820A1 (fr)
BG25827A2 (fr)
BG25839A1 (fr)
BG25837A1 (fr)
BG25826A1 (fr)
BG25828A1 (fr)
BG25840A1 (fr)
BG25825A1 (fr)
BE872973A (fr)
BG25841A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse